NCT03463733 Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma) Status UNKNOWN Phase PHASE1
NCT03426891 Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1
NCT03425292 A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer Status COMPLETED Phase PHASE1
NCT03422445 A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma Status UNKNOWN Phase PHASE2
NCT03419403 UNITE Study: Understanding New Interventions With GBM ThErapy Status TERMINATED Phase PHASE3
NCT03388372 Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma Status COMPLETED Phase PHASE2
NCT03387592 CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas Status TERMINATED Phase PHASE2
NCT03363659 Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme Status TERMINATED Phase PHASE2
NCT03351296 Two Chemotherapy Regimens Plus or Minus Bevacizumab Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03345095 A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE3
NCT03323034 Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT03310372 Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT03291990 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme Status COMPLETED Phase EARLY_PHASE1
NCT03246113 Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma Status TERMINATED Phase PHASE1
NCT03232424 NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1
NCT03224104 Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma. Status COMPLETED Phase PHASE1
NCT03213002 Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM Status RECRUITING Phase PHASE1/PHASE2
NCT03204032 A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor Status UNKNOWN Phase PHASE2